NCT06973304 - A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

February 10, 2027

Study Completion Date

July 28, 2027

Conditions

Short Bowel Syndrome

Interventions

DRUG

Teduglutide

Teduglutide 0.05 mg/kg SC injection.

Trial Locations (4)

RECRUITING

Peking Union Medical College Hospital, Dongcheng

RECRUITING

Beijing Tsinghua Changgung Hospital, Changping

RECRUITING

Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing

RECRUITING

Zhongshan Hospital, Xiamen University, Siming